Tendersinfo Gulf

Filter Search

Healthcare and Medical

Location Summary Deadline
Germany Medicines Containing The Active Ingredient Combination Formoterol And Beclometasone (atc: R03ak08 - In The Strength 200/6 Micrograms) 2026-10-31
Germany Medicines Containing The Active Ingredient Rituximab - In The Dosage Form Concentrate For Infusion Solution (atc: L01fa01) 2026-10-31
Germany Pharmaceutical Contracts With Accession Option 2026-11-01
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V (open House Model) 2026-11-01
Germany Drug Discount Agreements From 01.01.2025 For Various Active Ingredients Within The Framework Of An Open House Procedure 2026-11-02
Germany Drug Discount Agreements Pursuant To Section 130a Para. 8 Sgb V Within The Framework Of Open House Procedures - Drug 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Ginkgo Biloba Leaf Dry Extract, (obg) Atc N06dp01 For The Period 01.01.2025 31.12.2026 2026-11-05
Germany Open House Drug Discount Agreements Lipegfilgrastim, Atc L03aa14 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Rotigotine, (obg) Atc N04bc09 For The Period 01.01.2025 31.12.2026 2026-11-05
Germany Conclusion Of A Non-exclusive Discount Agreement Pursuant To Section 130a Para. 8 Sgb V For The Active Ingredient Pyridostigmine (excluding Sustained-release Dafo.), (obg) Atc N07aa02 For The Period 01.01.2025 31.12.2026 2026-11-05
Whats app